Search Results - "TAN, E. V"

Refine Results
  1. 1

    Novel prophylactic and therapeutic vaccine against tuberculosis by Okada, Masaji, Kita, Yoko, Nakajima, Toshihiro, Kanamaru, Noriko, Hashimoto, Satomi, Nagasawa, Tetsuji, Kaneda, Yasufumi, Yoshida, Shigeto, Nishida, Yasuko, Nakatani, Hitoshi, Takao, Kyoko, Kishigami, Chie, Inoue, Yoshikazu, Matsumoto, Makoto, McMurray, David N, dela Cruz, E.C, Tan, E.V, Abalos, R.M, Burgos, J.A, Saunderson, Paul, Sakatani, Mitsunori

    Published in Vaccine (26-05-2009)
    “…Abstract We have developed a novel tuberculosis (TB) vaccine; a combination of the DNA vaccines expressing mycobacterial heat shock protein 65 (HSP65) and…”
    Get full text
    Journal Article Conference Proceeding
  2. 2
  3. 3
  4. 4

    Parotid abscess: a five-year review--clinical presentation, diagnosis and management by Tan, V E S, Goh, B S

    Published in Journal of laryngology and otology (01-09-2007)
    “…Parotid abscess is an uncommon complication of suppurative infection of the parotid gland parenchyma, commonly bacterial or viral. Ductal ectasis, primary…”
    Get more information
    Journal Article
  5. 5

    Parapharyngeal abscess complicated by endophthalmitis: a rare presentation of nasopharyngeal carcinoma by Tan, V E S, Jeevanan, J, Lee, B R

    Published in Journal of laryngology and otology (01-08-2008)
    “…We report an extremely rare case of nasopharyngeal carcinoma presenting as a lateral neck abscess complicated by endogenous bacterial endophthalmitis…”
    Get more information
    Journal Article
  6. 6

    Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC™): results of an open-label trial by Balagon, M. V., Tan, P. L., Prestidge, R., Cellona, R. V., Abalos, R. M., Tan, E. V., Walsh, G. P., Watson, J. D., Walsh, D. S.

    Published in Clinical and experimental dermatology (01-05-2001)
    “…The aim of new treatments for psoriasis is to induce extended remissions with fewer side‐effects. Previous studies suggest that Mycobacterium vaccae, a…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Improvement in psoriasis after intradermal administration of heat-killed Mycobacterium vaccae by Balagon, Maria V., Walsh, Douglas S., Tan, Paul L., Cellona, Roland V., Abalos, Rodolfo M., Tan, Esterlina V., Fajardo Jr, Tranquilino T., Watson, James D., Walsh, Gerald P.

    Published in International journal of dermatology (01-01-2000)
    “…Background New treatments for psoriasis are being developed, but many are associated with limited efficacy, side‐effects, or rapid recurrence after…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    The Philippine cynomolgus monkey ( Macaca fasicularis ) provides a new nonhuman primate model of tuberculosis that resembles human disease by Walsh, Gerald P, Tan, Esterlina V, Dela Cruz, Eduardo C, Abalos, Rodolfo M, Villahermosa, Laarni G, Young, Leon J, Cellona, Roland V, Narareno, Jerome B, Horwitz, Marcus A

    Published in Nature medicine (01-04-1996)
    “…A nonhuman primate model of tuberculosis that closely resembles human disease is urgently needed. We have evaluated the Philippine cynomolgus monkey, Macaca…”
    Get full text
    Journal Article
  14. 14

    A Novel Therapeutic and Prophylactic Vaccine against Tuberculosis Using the Cynomolgus Monkey Model and Mouse Model by Okada, M., Kita, Y., Nakajima, T., Kanamaru, N., Kaneda, Y., Saunderson, P., Tan, E.V., McMurray, DN

    Published in Procedia in vaccinology (2011)
    “…We have developed a novel tuberculosis (TB) vaccine; a combination of the DNA vaccines expressing mycobacterial heat shock protein 65 (HSP65) and interleukin…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Primary dapsone resistance in Cebu, The Philippines; cause for concern by dela Cruz, E, Cellona, R V, Balagon, M V, Villahermosa, L G, Fajardo, Jr, T T, Abalos, R M, Tan, E V, Walsh, G P

    “…At a time when primary dapsone resistance was prevalent in many leprosy endemic areas, Cebu in The Philippines reported only 3.6% in the period 1975-1978 and…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy by Cho, S N, Cellona, R V, Villahermosa, L G, Fajardo, Jr, T T, Balagon, M V, Abalos, R M, Tan, E V, Walsh, G P, Kim, J D, Brennan, P J

    “…A total of 100 untreated new leprosy patients were recruited prospectively and examined for the presence of phenolic glycolipid I (PGL-I) antigen in their…”
    Get full text
    Journal Article
  19. 19

    Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST® CMI by WALSH, D. S, VILLAHERMOSA, L. G, BALAGON, M. V, ABALOS, R. M, FAJARDO, T. T, TAN, E. V, CELLONA, R. V, WALSH, G. P

    “…To assess cell mediated immune (CMI) function in patients with lepromatous and borderline lepromatous leprosy (LL and BL), 35 patients were examined with the…”
    Get full text
    Journal Article
  20. 20